What were Krsnaa Diagnostics Ltd's latest quarterly results?
Krsnaa Diagnostics Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -21.1%
- Revenue Growth YoY: +3.4%
- Operating Margin: 26.0%
Krsnaa Diagnostics Ltd (Diagnostics) — fundamental analysis, earnings data, and key metrics. PE: 22.1. ROE: 8.8%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Krsnaa Diagnostics Ltd's latest quarterly results (Dec 2025) show
Krsnaa Diagnostics Ltd's current PE ratio is 22.1x.
Krsnaa Diagnostics Ltd's price-to-book ratio is 1.9x.
Krsnaa Diagnostics Ltd's fundamental strength based on key financial ratios
Krsnaa Diagnostics Ltd has a debt-to-equity ratio of N/A.
Krsnaa Diagnostics Ltd's return ratios over recent years
Krsnaa Diagnostics Ltd's operating cash flow is positive (FY2025).
Krsnaa Diagnostics Ltd's current dividend yield is 0.50%.
Krsnaa Diagnostics Ltd's shareholding pattern (Dec 2025)
Krsnaa Diagnostics Ltd's promoter holding has remained stable recently.
Krsnaa Diagnostics Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Krsnaa Diagnostics Ltd may be worth studying
Krsnaa Diagnostics Ltd investment thesis summary:
Krsnaa Diagnostics Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.